The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Rifaximin (Brand name: Normix)
- Manufactured by
Salix Pharmaceuticals, Inc.
FDA-approved indication: Reduction in the risk of overt hepatic encephalopathy (HE) recurrence in patients greater than or equal to 18 years of age.
National Library of Medicine Drug Information Portal